19581631

Source:http://linkedlifedata.com/resource/pubmed/id/19581631

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:19581631	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:19581631	lifeskim:mentions	umls-concept:C0019693	lld:lifeskim
pubmed-article:19581631	lifeskim:mentions	umls-concept:C0008976	lld:lifeskim
pubmed-article:19581631	lifeskim:mentions	umls-concept:C0034656	lld:lifeskim
pubmed-article:19581631	lifeskim:mentions	umls-concept:C1705413	lld:lifeskim
pubmed-article:19581631	lifeskim:mentions	umls-concept:C0674428	lld:lifeskim
pubmed-article:19581631	pubmed:issue	3	lld:pubmed
pubmed-article:19581631	pubmed:dateCreated	2009-8-4	lld:pubmed
pubmed-article:19581631	pubmed:databankReference	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19581631	pubmed:abstractText	More than 50% of patients who start efavirenz treatment develop limiting neuropsychiatric adverse events (NPAEs).	lld:pubmed
pubmed-article:19581631	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19581631	pubmed:language	eng	lld:pubmed
pubmed-article:19581631	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19581631	pubmed:citationSubset	AIM	lld:pubmed
pubmed-article:19581631	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19581631	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19581631	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19581631	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19581631	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:19581631	pubmed:month	Aug	lld:pubmed
pubmed-article:19581631	pubmed:issn	1539-3704	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:RiveroAntonio...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:VicianaPompey...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:PalaciosRosar...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:López-CortésL...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:Ruiz-Valderas...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:LozanoFernand...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:TerrónAlberto...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:Sociedad...	lld:pubmed
pubmed-article:19581631	pubmed:author	pubmed-author:Gutiérrez-Val...	lld:pubmed
pubmed-article:19581631	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:19581631	pubmed:day	4	lld:pubmed
pubmed-article:19581631	pubmed:volume	151	lld:pubmed
pubmed-article:19581631	pubmed:owner	NLM	lld:pubmed
pubmed-article:19581631	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:19581631	pubmed:pagination	149-56	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:meshHeading	pubmed-meshheading:19581631...	lld:pubmed
pubmed-article:19581631	pubmed:year	2009	lld:pubmed
pubmed-article:19581631	pubmed:articleTitle	Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.	lld:pubmed
pubmed-article:19581631	pubmed:affiliation	Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, and Hospital Universitario de Valme, Seville, Spain.	lld:pubmed
pubmed-article:19581631	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:19581631	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:19581631	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:19581631	pubmed:publicationType	Multicenter Study	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:19581631	lld:pubmed